Emily von Scheven, M.D.

Chief of Rheumatology

Dr. Emily von Scheven is director of the UCSF Pediatric Rheumatology Program. She specializes in the treatment of children with rheumatic diseases such as lupus and juvenile rheumatoid arthritis. von Scheven conducts a monthly specialty clinic for children with anti-phospholipid antibodies. Her research focuses on lupus, anti-phospholipid antibody syndrome and osteoporosis. She is evaluating approaches for measuring bone density and studying treatments for children with osteoporosis.

Von Scheven is also director of the pediatric rheumatology fellowship and UCSF Site Director for the Glaser Pediatric Research Network, a five-hospital collaborative program in the U.S. She received a medical degree from Pennsylvania State University, completed a residency in pediatrics at Children's National Medical Center in Washington, D.C., and completed a fellowship in rheumatology at Children's Hospital Philadelphia.

Clinics

Rheumatology Clinic
400 Parnassus Ave, Second Floor
San Francisco, CA 94143
Phone: (415) 353-7337

Conditions & Treatments

More about Emily von Scheven

Education

Pennsylvania State University School of Medicine 1989

Residencies

Children's National Medical Center, Pediatrics 1992

Fellowships

Children's Hospital Philadelphia, Rheumatology 1995

Selected Research and Publications

  1. von Scheven E, Corbin KJ, Stagi S, Cimaz R. Erratum to: Glucocorticoid-Associated Osteoporosis in Chronic Inflammatory Diseases: Epidemiology, Mechanisms, Diagnosis, and Treatment. Curr Osteoporos Rep. 2014 Sep; 12(3):383.
  2. von Scheven E, Corbin KJ, Stefano S, Cimaz R. Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment. Curr Osteoporos Rep. 2014 Sep; 12(3):289-99.
  3. Lawson EF, Hersh AO, Trupin L, von Scheven E, Okumura MJ, Yazdany J, Yelin EH. Educational and vocational outcomes of adults with childhood- and adult-onset systemic lupus erythematosus: nine years of followup. Arthritis Care Res (Hoboken). 2014 May; 66(5):717-24.
  4. von Scheven E, Punaro M, Ardoin SP, Brunner H, Hsu JJ, Mehta J, Wagner-Weiner L, Klein-Gitelman M, Rouster Stevens K, Haines KA, Schanberg L, Eberhard BA. A22: consensus treatment plans for induction therapy in childhood proliferative lupus nephritis-status of use in daily clinical care. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S35-6.
  5. Hersh AO, Son MB, von Scheven E. A85: effect of childhood-onset systemic lupus erythematosus on linear height and body mass index. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S118.
  6. Ardoin SP, Schanberg LE, Sandborg CI, Barnhart HX, Evans GW, Yow E, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, Levy D, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy DK, Klein-Gitelman M, Wallace C, Silver RM, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Thompson SD. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014 Mar 1; 73(3):557-66.
  7. Applebaum MA, Lawson EF, von Scheven E. Perception of transition readiness and preferences for use of technology in transition programs: teens' ideas for the future. Int J Adolesc Med Health. 2013; 25(2):119-25.
  8. Bernatsky S, Clarke AE, Labrecque J, von Scheven E, Schanberg LE, Silverman ED, Brunner HI, Haines KA, Cron RQ, O'Neil KM, Oen K, Rosenberg AM, Duffy CM, Joseph L, Lee JL, Kale M, Turnbull EM, Ramsey-Goldman R. Cancer risk in childhood-onset systemic lupus. Arthritis Res Ther. 2013; 15(6):R198.
  9. Mina R, Klein-Gitelman MS, Ravelli A, Beresford MW, Avcin T, Espada G, Eberhard BA, Schanberg LE, O'Neil KM, Silva CA, Higgins GC, Onel K, Singer NG, von Scheven E, Imundo LF, Nelson S, Giannini EH, Brunner HI. Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 May; 64(5):683-93.
  10. Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, Hsu J, Klein-Gitelman M, Moorthy LN, Muscal E, Radhakrishna SM, Wagner-Weiner L, Adams M, Blier P, Buckley L, Chalom E, Ch├ędeville G, Eichenfield A, Fish N, Henrickson M, Hersh AO, Hollister R, Jones O, Jung L, Levy D, Lopez-Benitez J, McCurdy D, Miettunen PM, Quintero-del Rio AI, Rothman D, Rullo O, Ruth N, Schanberg LE, Silverman E, Singer NG, Soep J, Syed R, Vogler LB, Yalcindag A, Yildirim-Toruner C, Wallace CA, Brunner HI. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):375-83.
  11. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Provenzale J, Thompson SD. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012 Jan; 64(1):285-96.
  12. Lawson EF, Hersh AO, Applebaum MA, Yelin EH, Okumura MJ, von Scheven E. Self-management skills in adolescents with chronic rheumatic disease: A cross-sectional survey. Pediatr Rheumatol Online J. 2011; 9(1):35.
  13. Brunner HI, Mina R, Pilkington C, Beresford MW, Reiff A, Levy DM, Tucker LB, Eberhard BA, Ravelli A, Schanberg LE, Saad-Magalhaes C, Higgins GC, Onel K, Singer NG, von Scheven E, Itert L, Klein-Gitelman MS, Punaro M, Ying J, Giannini EH. Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011 Sep; 63(9):1213-23.
  14. Hersh A, von Scheven E, Yelin E. Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol. 2011 May; 7(5):290-5.
  15. von Scheven E, Burnham JM. Vitamin D supplementation in the pediatric rheumatology clinic. Curr Rheumatol Rep. 2011 Apr; 13(2):110-6.
  16. Baker-LePain JC, Nakamura MC, Shepherd J, von Scheven E. Assessment of bone remodelling in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford). 2011 Mar; 50(3):611-9.
  17. Ardoin SP, Schanberg LE, Sandborg C, Yow E, Barnhart HX, Mieszkalski Kl, Ilowite NT, von Scheven E, Eberhard A, Levy DM, Kimura Y, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung LK, Imundo L, Soep JB, Reed AM. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010 Oct; 19(11):1315-25.
  18. Brunner HI, Klein-Gitelman MS, Higgins GC, Lapidus SK, Levy DM, Eberhard A, Singer N, Olson JC, Onel K, Punaro M, Schanberg L, von Scheven E, Ying J, Giannini EH. Toward the development of criteria for global flares in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010 Jun; 62(6):811-20.
  19. von Scheven E, Bakkaloglu A. What's new in paediatric SLE? Best Pract Res Clin Rheumatol. 2009 Oct; 23(5):699-708.
  20. Modica RF, Thundiyil JG, Chou C, Diab M, Von Scheven E. Teaching musculoskeletal physical diagnosis using a web-based tutorial and pathophysiology-focused cases. Med Educ Online. 2009; 14:13.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.